latest news releases from the newsroom
Port of Houston Authority
PHA Commission Delivers Bayport and Legislative Consulting Matters
HOUSTON, Oct. 17, 2005 (PRIMEZONE) -- The Port of Houston Authority (PHA) commission approved several recommendations involving contract awards, bids and proposals, professional services and general administrative and operational matters during its public meeting on Monday, Oct. 17, 2005. Additionally, they pulled three items related to the Bayport cruise facility. Chairman Jim Edmonds presided over the meeting with Vice Chairman Kase Lawal, Commissioner Steve Phelps, Commissioner Jim Fonteno, Commissioner Jimmy Burke, Commissioner Cheryl Thompson-Draper, and Commissioner Janiece Longoria.
The Pomerantz Firm Announces Additional Details Relevant to the Securities Fraud Litigation Against Refco, Inc. -- RFX
NEW YORK, Oct. 17, 2005 (PRIMEZONE) -- On October 12, 2005, Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) filed a class action complaint in the United States District Court, Southern District of New York, on behalf of investors who purchased the common stock of Refco, Inc. ("Refco" or "Company") (NYSE:RFX) between August 11, 2005 and October 7, 2005 ("Class Period"). Refco has now conceded that the Registration Statement that was issued in connection with its August 11, 2005 initial public offering ("IPO") contained false financials and failed to disclose $430 million in uncollectible debts owed to it by a company controlled by its CEO, Chairman and controlling shareholder Philip R. Bennett. Defendants in the case are Refco, Philip R. Bennett, Gerald M. Sherer (Refco's CFO), certain underwriters, and Refco's outside auditors, Grant Thornton LLP. Plaintiff seeks remedies under Sections 11 and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
Izard Nobel LLP
Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Tag-It Pacific, Inc. -- TAG
HARTFORD, Conn., Oct. 17, 2005 (PRIMEZONE) -- The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Central District of California on behalf of all persons who purchased the publicly traded securities of Tag-It Pacific, Inc. (AMEX:TAG) ("Tag-It") between November 14, 2003 and August 12, 2005 (the "Class Period").
Acura Pharmaceuticals Inc.
Acura Pharmaceuticals, Inc. Receives Clarification from FDA About Clinical Program; Cash Reserves Update
PALATINE, Ill., Oct. 17, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced receipt from the United States Food and Drug Administration ("FDA") communications clarifying previous FDA correspondence relating to the development of Product Candidate No. 2 announced by the Company on October 3, 2005. The FDA's most recent communication provides assurance that the Company may promptly resume planned clinical studies of Product Candidate No. 2 without conducting additional pre-clinical testing.